- Investing Ideas
- /
- Global Pharmaceuticals & Biotech High Growth Potential Companies
Global Pharmaceuticals & Biotech High Growth Potential Companies
UPDATED Apr 09, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
513 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ELAN | US$14.75 | -4.4% | 60.0% | US$7.5b | US$17.24 | PS1.6x | E91.3% | n/a | ||
NEU | AU$20.94 | 2.6% | 59.2% | AU$2.7b | AU$26.74 | PE17x | E5.2% | n/a | ||
BAYN | €27.40 | -4.8% | -54.4% | €26.9b | €37.71 | PB0.8x | E43.1% | 0.4% | ||
4503 | JP¥1,574.00 | -2.9% | -18.2% | JP¥2.8t | JP¥2,093.33 | PE672.3x | E30.0% | 4.4% | ||
ERF | €60.48 | 0.03% | -2.0% | €11.6b | €59.28 | PE45.3x | E19.7% | 0.8% | ||
BTAI | US$2.63 | -0.4% | -84.2% | US$78.6m | US$7.42 | PS58.3x | E40.3% | n/a | ||
PAHC | US$13.23 | 2.3% | -13.1% | US$531.4m | US$10.75 | PE36.2x | E33.2% | 3.6% | ||
JAZZ | US$114.08 | -2.4% | -20.8% | US$7.1b | US$188.64 | PE17.1x | E17.3% | n/a | ||
GLYC | US$2.68 | -9.5% | 97.1% | US$166.9m | US$7.00 | PS17272.7x | E63.0% | n/a | ||
PHAR | ج.م43.66 | 1.3% | 29.2% | ج.م6.5b | ج.م72.20 | PE7.9x | E14.2% | 2.3% | ||
603739 | CN¥10.68 | -5.2% | -24.1% | CN¥2.7b | n/a | PE38.1x | E28.2% | 0.9% | ||
6600 | HK$17.88 | 0% | 61.4% | HK$10.9b | HK$17.86 | PE9x | E4.7% | 0% | ||
300630 | CN¥17.54 | -2.5% | -39.3% | CN¥7.9b | n/a | PE21.3x | E21.5% | 0.4% | ||
LONN | CHF545.00 | 0.2% | -5.3% | CHF39.3b | CHF566.00 | PE60.1x | E20.0% | 0.7% | ||
ORY | €2.02 | -2.9% | -8.2% | €116.4m | €6.84 | PB1.5x | E60.6% | n/a | ||
CANTA | kr4.35 | 4.8% | -37.1% | kr798.7m | kr12.67 | PB4.7x | E60.1% | n/a | ||
ZEAL | kr.613.00 | -5.5% | 195.8% | kr.38.8b | kr.754.29 | PS111.4x | E44.6% | n/a | ||
4540 | JP¥3,926.00 | 4.1% | 48.2% | JP¥298.1b | JP¥4,793.33 | PE17.8x | E17.1% | 1.8% | ||
2269 | HK$14.34 | 2.1% | -71.3% | HK$59.8b | HK$30.82 | PE16.2x | E14.4% | n/a | ||
ALK B | kr.123.80 | -0.4% | 15.3% | kr.27.2b | kr.125.00 | PE56.3x | E31.0% | 0% | ||
TRUL | CA$16.50 | -6.0% | 133.7% | CA$3.3b | CA$22.36 | PS2x | E116.2% | n/a | ||
DMAC | US$2.65 | -5.4% | 55.9% | US$102.9m | US$7.00 | PB2x | E26.8% | n/a | ||
PBH | US$68.93 | -0.7% | 8.3% | US$3.4b | US$74.33 | PS3x | E34.5% | n/a | ||
VRTX | US$397.58 | -2.7% | 21.8% | US$104.5b | US$461.10 | PE28.4x | E11.2% | n/a |